TD Cowen analyst Joseph Thome maintained a Hold rating on PTC Therapeutics (PTCT – Research Report) today and set a price target of $50.00. The company’s shares closed yesterday at $45.19.
Shares of PTC Inc. PTC advanced 1.30% to $190.93 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.92% to 6,067.70 and the ...